Features of medical and social expertise in ankylosing spondylitis and psoriatic arthritis

Ankylosing spondylitis (AS) and psoriatic arthritis (PsA) are the two most common diseases from group of spondyloarthritis (SpA), which often accompanied by permanent disability. Maintaining an acceptable quality life, preventing development progression structural changes in musculoskeletal system, maintaining/normalizing functional social activity main goals their therapy. Over past decades, introduction biological disease modifying antirheumatic drugs has made it possible to achieve significant success sustainable control AS PsA activity. However, high cost treatment significantly limits access innovative drugs. Specifics drug supply call for prescription these presence status "disabled", is assigned on basis results medical examination (MSE). Execution necessary documentation implementation MSE one functions a rheumatologist.The lecture analyzes regulatory legal acts Russian Federation regulating issues establishing disability discusses peculiarities reports processing when referring patients with MSE.